Synthesis and Initial In Vivo Evaluation of [11C]AZ683-A Novel PET Radiotracer for Colony Stimulating Factor 1 Receptor (CSF1R)
- Pharmaceuticals (Basel). 2018 Dec 13;11(4):136. doi: 10.3390/ph11040136.
- 1. Department of Medicinal Chemistry, University of Michigan, Ann Arbor, MI 48109, USA. [email protected].
- 2. Department of Radiology, University of Michigan, Ann Arbor, MI 48109, USA. [email protected].
- 3. Department of Radiology, University of Michigan, Ann Arbor, MI 48109, USA. [email protected].
- 4. Department of Radiology, University of Michigan, Ann Arbor, MI 48109, USA. [email protected].
- 5. Department of Radiology, University of Michigan, Ann Arbor, MI 48109, USA. [email protected].
- 6. Department of Medicinal Chemistry, University of Michigan, Ann Arbor, MI 48109, USA. [email protected].
- 7. Department of Radiology, University of Michigan, Ann Arbor, MI 48109, USA. [email protected].
- 8. Department of Radiology, University of Michigan, Ann Arbor, MI 48109, USA. [email protected].
Positron emission tomography (PET) imaging of Colony Stimulating Factor 1 Receptor (CSF1R) is a new strategy for quantifying both neuroinflammation and inflammation in the periphery since CSF1R is expressed on microglia and macrophages. AZ683 has high affinity for CSF1R (Ki = 8 nM; IC50 = 6 nM) and >250-fold selectivity over 95 Other kinases. In this paper, we report the radiosynthesis of [11C]AZ683 and initial evaluation of its use in CSF1R PET. [11C]AZ683 was synthesized by 11C-methylation of the desmethyl precursor with [11C]MeOTf in 3.0% non-corrected activity yield (based upon [11C]MeOTf), >99% radiochemical purity and high molar activity. Preliminary PET imaging with [11C]AZ683 revealed low brain uptake in rodents and nonhuman primates, suggesting that imaging neuroinflammation could be challenging but that the radiopharmaceutical could still be useful for peripheral imaging of inflammation.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: c-FmsResearch Areas: Cardiovascular Disease